Skip to main content
Top

Current Hepatology Reports

Issue 2/2019

Content (16 Articles)

Open Access Rituximab Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)

Management of Fatigue in Primary Biliary Cholangitis

Amardeep Khanna, Vinod S. Hegade, David E. Jones

Fatty Liver Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Portal Hypertension in NASH: Is It Different from Other Aetiologies?

Sven M. Francque, W. J. Kwanten, D. van der Graaff

Ascites Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?

Gennaro D’Amico, Giovanni Perricone

Ascites Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

The Role of Hepatic and Splanchnic Lymphatic System in Portal Hypertension and Ascites

Jordi Ribera, Bernat Córdoba-Jover, Irene Portolés, Manuel Morales-Ruiz

Propranolol Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

HVPG Measurements as a Surrogate of Clinical Events in Cirrhosis: Experience from Clinical Trials

Maria Gabriela Delgado, Jaume Bosch

Open Access Propranolol Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring?

Mattias Mandorfer, Virginia Hernández-Gea, Thomas Reiberger, Juan Carlos García-Pagán

Open Access Statins Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Novel Targets and Drug Development in Portal Hypertension

Robert Schierwagen, Sabine Klein, Frank Uschner, Jonel Trebicka

Hepatic Encephalopathy Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Patient Selection in Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Refractory Ascites and Associated Conditions

Beverley Kok, Juan Gonzalez Abraldes

Ledipasvir Hepatitis C (H Vargas and S Flamm, Section Editors)

Testing for Hepatitis C in Pregnancy: the Time Has Come for Routine Rather than Risk-Based

Tatyana Kushner, Catherine A. Chappell, Arthur Y. Kim

Dasabuvir Hepatitis C (H Vargas and S Flamm, Section Editors)

Acute HCV Treatment: What Should We Do in the DAA Era?

Zurabi Lominadze, Robert S. Brown Jr

Antiviral Agents Hepatitis C (H Vargas and S Flamm, Section Editors)

HCV Exposure in the Health Care Arena. Is there a Role for Post-exposure Prophylaxis?

Ryan S. Chiang, Andrew J. Muir

Kidney Transplantation Hepatitis C (H Vargas and S Flamm, Section Editors)

Hepatitis C-Positive Organs for Liver and Kidney Transplantation—Emerging Data and Current Management Strategies

Blanca C. Lizaola-Mayo, Hugo E. Vargas, David M. Chascsa

Liver Transplantation Hepatitis C (H Vargas and S Flamm, Section Editors)

The Use of Grafts from HCV+ Patients in Transplantation: Are we There Yet?

Kathy M. Nilles, Steven L. Flamm

Dasabuvir Hepatitis C (H Vargas and S Flamm, Section Editors)

State of the Art HCV Treatment in Children

Christine K. Lee, Maureen M. Jonas

Hepatitis C Hepatitis C (H Vargas and S Flamm, Section Editors)

HCV Management in the Incarcerated Population: How Do We Deliver on This Important Front?

Javier Crespo, Susana Llerena, Carmen Cobo, Joaquin Cabezas, Antonio Cuadrado

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.